- Home
- IDYA vs SVV Comparison
IDYA vs SVV Comparison
Compare IDYA & SVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- SVV
- Stock Information
- Founded
- IDYA 2015
- SVV 1954
- Country
- IDYA United States
- SVV United States
- Employees
- IDYA N/A
- SVV N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- SVV Other Specialty Stores
- Sector
- IDYA Health Care
- SVV Consumer Discretionary
- Exchange
- IDYA Nasdaq
- SVV Nasdaq
- Market Cap
- IDYA 2.3B
- SVV 2.1B
- IPO Year
- IDYA 2019
- SVV 2023
- Fundamental
- Price
- IDYA $31.60
- SVV $13.23
- Analyst Decision
- IDYA Buy
- SVV Buy
- Analyst Count
- IDYA 17
- SVV 7
- Target Price
- IDYA $48.20
- SVV $13.17
- AVG Volume (30 Days)
- IDYA 1.3M
- SVV 1.1M
- Earning Date
- IDYA 11-04-2025
- SVV 10-30-2025
- Dividend Yield
- IDYA N/A
- SVV N/A
- EPS Growth
- IDYA N/A
- SVV N/A
- EPS
- IDYA N/A
- SVV N/A
- Revenue
- IDYA $7,000,000.00
- SVV $1,616,273,000.00
- Revenue This Year
- IDYA $90.17
- SVV $10.11
- Revenue Next Year
- IDYA $219.42
- SVV $7.09
- P/E Ratio
- IDYA N/A
- SVV N/A
- Revenue Growth
- IDYA N/A
- SVV 6.45
- 52 Week Low
- IDYA $13.45
- SVV $6.48
- 52 Week High
- IDYA $33.64
- SVV $13.89
- Technical
- Relative Strength Index (RSI)
- IDYA 63.75
- SVV 54.34
- Support Level
- IDYA $28.17
- SVV $12.28
- Resistance Level
- IDYA $33.64
- SVV $13.88
- Average True Range (ATR)
- IDYA 1.70
- SVV 0.50
- MACD
- IDYA 0.33
- SVV 0.02
- Stochastic Oscillator
- IDYA 72.58
- SVV 59.37
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
About SVV Savers Value Village Inc.
Savers Value Village Inc is a for-profit thrift operator in the United States and Canada. It purchases second hand textiles (i.e., clothing, bedding, and bath items), shoes, accessories, housewares, books, and other goods from its non-profit partners (NPPs), either directly from them or via on-site donations (OSDs) at Community Donation Centers at its stores. The company then processes, selects, prices, merchandise, and sells these items in its stores.